Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Research Article

Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves’ Ophthalmopathy

Author(s): Rong-Hua Song, Bin Wang, Qiu-Ming Yao, Qian Li, Xi Jia and Jin-An Zhang*

Volume 20 , Issue 1 , 2020

Page: [87 - 95] Pages: 9

DOI: 10.2174/1871530319666190618142215

Price: $65

Abstract

Background: The current study aimed at exploring the cytokine profile in the tears of patients with Graves’ ophthalmopathy (GO).

Methods: Tears were sampled from the eyes of 7 patients with active GO and 7 healthy volunteers using filter paper. Then the levels of up to 34 cytokines in the tears of each subject were detected using high-throughput protein microarray technology in line with the introduction.

Results: The results of cytokine protein microarray screening showed that 10 proteins, namely, CD40, CD40 Ligand, GITR, IL-12p70, IL-1 beta, IL-2, IL-21, IL-6, MIP-3 alpha and TRANCE, were overexpressed (with fold change >1.20) and 3 proteins, namely, GM-CSF, IL-1 sRI and IL-13 were downregulated (with fold change < 0.83) in GO patients. In addition, the protein levels of CD40 and CD40 ligand (CD40L) were significantly different between GO patients and healthy controls (P=0.028 and 0.011, respectively). Further Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses of differently expressed proteins showed that these proteins were involved in biological functions including biological processes (positive regulation of cytokine production, JAK-STAT cascade and leukocyte proliferation), molecular functions (cytokine and growth factor receptors binding and cytokine activity), and other important pathways (cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, IL-17 signaling pathway, NF-kappa B signaling pathway, Th17 cell differentiation, and intestinal immune network for IgA production), all of which might be involved in the pathology of GO.

Conclusion: Our cytokine protein microarray analysis indicated that several proteins were differentially expressed in GO patients, which provides potential targets for GO prevention.

Keywords: Graves’ ophthalmopathy, cytokine, protein microarray, CD40, CD40 ligand, tear.

Graphical Abstract
[1]
Wall, J.R.; Lahooti, H. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases? Endokrynol. Pol., 2010, 61(2), 222-227.
[PMID: 20464711]
[2]
Perros, P.; Neoh, C.; Dickinson, J. Thyroid eye disease. BMJ, 2009, 338, b560.
[http://dx.doi.org/10.1136/bmj.b560] [PMID: 19270020]
[3]
Phelps, P.O.; Williams, K. Thyroid eye disease for the primary care physician. Dis. Mon., 2014, 60(6), 292-298.
[http://dx.doi.org/10.1016/j.disamonth.2014.03.010] [PMID: 24906675]
[4]
Wu, S.; Cai, T.; Chen, F.; He, X.; Cui, Z. Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population. Int. J. Clin. Exp. Med., 2015, 8(9), 16948-16954.
[PMID: 26629249]
[5]
Xiao, L.; Muhali, F.S.; Cai, T.T.; Song, R.H.; Hu, R.; Shi, X.H.; Jiang, W.J.; Li, D.F.; He, S.T.; Xu, J.; Zhang, J.A. Association of single-nucleotide polymorphisms in the STAT3 gene with autoimmune thyroid disease in Chinese individuals. Funct. Integr. Genomics, 2013, 13(4), 455-461.
[http://dx.doi.org/10.1007/s10142-013-0337-0] [PMID: 24081513]
[6]
Song, R.H.; Li, Q.; Wang, W.; Yao, Q.M.; Shao, X.Q.; Zhang, J.A. Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease. Int. J. Endocrinol., 2017. 20173428236
[http://dx.doi.org/10.1155/2017/3428236] [PMID: 28839453]
[7]
Weiler, D.L. Thyroid eye disease: a review. Clin. Exp. Optom., 2017, 100(1), 20-25.
[http://dx.doi.org/10.1111/cxo.12472] [PMID: 27701774]
[8]
Melcescu, E.; Horton, W.B.; Kim, D.; Vijayakumar, V.; Corbett, J.J.; Crowder, K.W.; Pitman, K.T.; Uwaifo, G.I.; Koch, C.A. Graves orbitopathy: update on diagnosis and therapy. South. Med. J., 2014, 107(1), 34-43.
[http://dx.doi.org/10.1097/SMJ.0000000000000038] [PMID: 24389785]
[9]
Huang, D.; Xu, N.; Song, Y.; Wang, P.; Yang, H. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch. Clin. Exp. Ophthalmol., 2012, 250(4), 619-625.
[http://dx.doi.org/10.1007/s00417-011-1863-x] [PMID: 22124787]
[10]
Shen, J.; Li, Z.; Li, W.; Ge, Y.; Xie, M.; Lv, M.; Fan, Y.; Chen, Z.; Zhao, D.; Han, Y. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy. Dis. Markers, 2015. 2015609593
[http://dx.doi.org/10.1155/2015/609593] [PMID: 26089587]
[11]
Barrio-Barrio, J.; Sabater, A.L.; Bonet-Farriol, E.; Velázquez-Villoria, Á.; Galofré, J.C. Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management. J. Ophthalmol., 2015. 2015249125
[http://dx.doi.org/10.1155/2015/249125] [PMID: 26351570]
[12]
Bartalena, L.; Baldeschi, L.; Dickinson, A.J.; Eckstein, A.; Kendall-Taylor, P.; Marcocci, C.; Mourits, M.P.; Perros, P.; Boboridis, K.; Boschi, A.; Currò, N.; Daumerie, C.; Kahaly, G.J.; Krassas, G.; Lane, C.M.; Lazarus, J.H.; Marinò, M.; Nardi, M.; Neoh, C.; Orgiazzi, J.; Pearce, S.; Pinchera, A.; Pitz, S.; Salvi, M.; Sivelli, P.; Stahl, M.; von Arx, G.; Wiersinga, W.M. Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid, 2008, 18(3), 333-346.
[http://dx.doi.org/10.1089/thy.2007.0315] [PMID: 18341379]
[13]
Okrojek, R.; Grus, F.H.; Matheis, N.; Kahaly, G.J. Proteomics in autoimmune thyroid eye disease. Horm. Metab. Res., 2009, 41(6), 465-470.
[http://dx.doi.org/10.1055/s-0029-1214413] [PMID: 19373747]
[14]
Gianoukakis, A.G.; Khadavi, N.; Smith, T.J. Cytokines, Graves’ disease, and thyroid-associated ophthalmopathy. Thyroid, 2008, 18(9), 953-958.
[http://dx.doi.org/10.1089/thy.2007.0405] [PMID: 18713026]
[15]
Wakelkamp, I.M.; Bakker, O.; Baldeschi, L.; Wiersinga, W.M.; Prummel, M.F. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients. Clin. Endocrinol. (Oxf.), 2003, 58(3), 280-287.
[http://dx.doi.org/10.1046/j.1365-2265.2003.01708.x] [PMID: 12608932]
[16]
Pawlowski, P.; Wawrusiewicz-Kurylonek, N.; Eckstein, A.; Reszec, J.; Luczynski, W.; Johnson, K.; Kretowski, A.; Bakunowicz-Lazarczyk, A.; Gorska, M.; Szamatowicz, J.; Chyczewski, L.; Mysliwiec, J. Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves’ ophthalmopathy. Mediators Inflamm., 2015. 2015340934
[http://dx.doi.org/10.1155/2015/340934] [PMID: 25653477]
[17]
Myśliwiec, J.; Waligórski, D.; Nikołajuk, A.; Górska, M. Soluble CD40 and its ligand CD154 in patients with Graves’ ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy. Adv. Med. Sci., 2007, 52, 104-108.
[PMID: 18217399]
[18]
Wakelkamp, I.M.; Gerding, M.N.; Van Der Meer, J.W.; Prummel, M.F.; Wiersinga, W.M. Both Th1- and Th2-derived cytokines in serum are elevated in Graves’ ophthalmopathy. Clin. Exp. Immunol., 2000, 121(3), 453-457.
[http://dx.doi.org/10.1046/j.1365-2249.2000.01335.x] [PMID: 10971510]
[19]
Kumar, S.; Bahn, R.S. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves’ ophthalmopathy. J. Clin. Endocrinol. Metab., 2003, 88(9), 4246-4250.
[http://dx.doi.org/10.1210/jc.2003-030380] [PMID: 12970294]
[20]
Lv, M.; Shen, J.; Li, Z.; Zhao, D.; Chen, Z.; Wan, H.; Hao, B. [Role of Treg/Th17 cells and related cytokines in Graves’ ophthalmopathy] Nan Fang Yi Ke Da Xue Xue Bao, 2014, 34(12), 1809-1813. [Role of Treg/Th17 cells and related cytokines in Graves' ophthalmopathy]
[PMID: 25537908]
[21]
Ujhelyi, B.; Gogolak, P.; Erdei, A.; Nagy, V.; Balazs, E.; Rajnavolgyi, E.; Berta, A.; Nagy, E.V. Graves’ orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid, 2012, 22(4), 407-414.
[http://dx.doi.org/10.1089/thy.2011.0248] [PMID: 22385289]
[22]
Jia, H.Y.; Zhang, Z.G.; Gu, X.J.; Guo, T.; Cui, B.; Ning, G.; Zhao, Y.J. Association between interleukin 21 and Graves’ disease. Genet. Mol. Res., 2011, 10(4), 3338-3346.
[http://dx.doi.org/10.4238/2011.October.31.6] [PMID: 22057994]
[23]
Li, C.; Yuan, J.; Zhu, Y.F.; Yang, X.J.; Wang, Q.; Xu, J.; He, S.T.; Zhang, J.A. Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases. Cell. Physiol. Biochem., 2016, 40(1-2), 245-252.
[http://dx.doi.org/10.1159/000452541] [PMID: 27855396]
[24]
Fang, S.; Huang, Y.; Zhong, S.; Zhang, Y.; Liu, X.; Wang, Y.; Gu, P.; Zhou, H.; Fan, X. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy. Invest. Ophthalmol. Vis. Sci., 2016, 57(14), 6123-6133.
[http://dx.doi.org/10.1167/iovs.16-20199] [PMID: 27832278]
[25]
Fang, S.; Huang, Y.; Zhong, S.; Li, Y.; Zhang, Y.; Li, Y.; Sun, J.; Liu, X.; Wang, Y.; Zhang, S.; Xu, T.; Sun, X.; Gu, P.; Li, D.; Zhou, H.; Li, B.; Fan, X. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy. J. Clin. Endocrinol. Metab., 2017, 102(11), 4273-4283.
[http://dx.doi.org/10.1210/jc.2017-01349] [PMID: 28938397]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy